SUPPORT HOTLINE (888) 901-2226
Donate Now


Bladder Cancer CME Program

A New Paradigm in Urothelial Cancer: The Convergence of Immuno-Oncology and Urology A CME breakfast symposium to be held on Sunday, May 20, 2018 For more information, please visit Activity Chair: Ashish M. Kamat, MD, MBBS, FACS Speakers Arjun V. Balar, MD Robert Dreicer, MD, MS, MACP, FASCO Neal

Read More

IRA Charitable Rollover for Planned Giving

The IRA Charitable Rollover provides you with an excellent opportunity to make a gift during your lifetime from an asset that would be subject to multiple levels of taxation if it remained in your taxable estate. Planned Giving Chart

Read More

Fundraising and Donor Privacy Policies & Procedures

Introduction. The Bladder Cancer Advocacy Network (BCAN) is a nonprofit organization committed to providing services to members of the bladder cancer community.  All donations solicited on behalf of BCAN shall be used to further this mission and follow the policies and procedures outlined below. Fundraising Policy. Funds shall be solicited

Read More

Privacy Policy

Your privacy is very important to us.  This privacy policy sets forth the information we may collect about you and how we use this information. We do not require submission of any personally identifiable information from you to use this web site.  However, in order to participate in certain services

Read More

2016 BCAN Young Investigator Awardees

The Stephen Hale Gushée Young Investigator Award will support Kent William Mouw, M.D., Ph.D. of Dana-Farber Cancer Institute, for his research “Identifying Genomic Determinants of Chemoradiotherapy Response in Muscle-Invasive Bladder Cancer.” Dr. Mouw’s study will leverage new genomic techniques to better understand how these biomarkers can benefit muscle invasive bladder cancer

Read More

2017 BCAN Young Investigator Awardees

The Stephen Hale Gushée Young Investigator Award will support the research of Tracy Rose, MD, MPH, Assistant Professor at UNC Chapel Hill, for her research, “Defining the Immune Response to Chemotherapy and Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer.” While newly approved immunotherapy treatments are showing great promise for many bladder cancer

Read More